ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

Advocacy Group Amasses Support For Bill That Threatens Integrity of NCI Peer Review

August 3, 2012

Three Nutrition RFPs withdrawn Due To “Vagueness”

July 8, 1977